GlassScriptPhysician profile
Stephanie Caughman
NPI 1366493975
$1,581.35
in general payments reported to CMS, 2019-2025
17 companies · $268 in 2025
The $268 reported for 2025 was more than what 82% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $265 · 2022: $264 · 2023: $484 · 2024: $300 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,052.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,052.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $422.96 | 2022-2025 | Azstarys |
| Pfizer INC. | $187.22 | 2021-2023 | |
| Ironshore Pharmaceuticals INC. | $167.85 | 2022-2024 | Jornay Pm |
| Merck Sharp & Dohme LLC | $160.48 | 2021-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Takeda Pharmaceuticals U.S.A., INC. | $145.53 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $93.48 | 2022-2023 | Qelbree |
| Sanofi Pasteur INC. | $78.11 | 2021-2024 | |
| Collegium Pharmaceutical, INC. | $56.09 | 2025 | Jornay Pm |
| Sobi, INC | $52.73 | 2022-2023 | |
| Kowa Pharmaceuticals America, INC. | $50.22 | 2025 | Zoryve |
| Biogen, INC. | $34.68 | 2024-2025 | Skyclarys |
| Vertical Pharmaceuticals, LLC | $32.86 | 2025 | Relexxii |
| Seqirus USA INC | $28.42 | 2022-2023 | Flucelvax Quadrivalent |
| Ars Pharmaceuticals Operations, INC. | $23.95 | 2025 | Neffy |
| Alk-Abello, INC | $19.72 | 2023 | Ragwitek, Odactra, Grastek |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $15.42 | 2023 | Bexsero |
| Kaleo, INC. | $11.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Caughman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.